(Q50624029)

16 March 2018

title

Benign prostatic hyperplasia in Sweden 1987 to 1994: changing patterns of treatment, changing patterns of costs. (English)

1 reference

16 March 2018

main subject

Sweden

0 references

prostatic hypertrophy

1 reference

2

Ekbom A

1 reference

16 March 2018

Blomqvist P

1

1 reference

16 March 2018

Carlsson P

series ordinal

3

1 reference

16 March 2018

Ahlstrand C

series ordinal

4

1 reference

16 March 2018

Johansson JE

series ordinal

5

1 reference

16 March 2018

language of work or name

English

0 references

publication date

1 August 1997

1 reference

16 March 2018

published in

Urology

1 reference

16 March 2018

volume

50

1 reference

16 March 2018

issue

2

1 reference

16 March 2018

page(s)

214-9; discussion 219-20

1 reference

16 March 2018

The prevalence of prostatism: a population-based survey of urinary symptoms

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900241-0

7 January 2021

Benign prostatic hyperplasia. Medical and minimally invasive treatment options

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900241-0

7 January 2021

Are the days of transurethral resection of prostate for benign prostatic hyperplasia numbered? Urologists must grasp the future

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900241-0

7 January 2021

Are the days of transurethral resection of prostate for benign prostatic hyperplasia numbered? Alternatives are still unproved

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900241-0

7 January 2021

Economic burden of treated benign prostatic hyperplasia in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900241-0

7 January 2021

Estimated total costs of treating benign prostatic hyperplasia in Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900241-0

7 January 2021

An estimate of the life-time cost of surgical treatment of patients with benign prostatic hyperplasia in Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900241-0

7 January 2021

Transurethral microwave treatment for benign prostatic hypertrophy: a randomised controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900241-0

7 January 2021

Sham versus transurethral microwave thermotherapy in patients with symptoms of benign prostatic bladder outflow obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900241-0

7 January 2021

A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900241-0

7 January 2021

Can finasteride reverse the progress of benign prostatic hyperplasia? A two-year placebo-controlled study. The Scandinavian BPH Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900241-0

7 January 2021

The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900241-0

7 January 2021

Economic issues and the management of benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900241-0

7 January 2021

Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900241-0

7 January 2021

Mortality after prostatectomy: selection and surgical approach

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900241-0

7 January 2021

10.1016/S0090-4295(97)00241-0

Identifiers

DOI

1 reference

16 March 2018

1 reference

16 March 2018